CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-16 | Kelly James Patrick EVP, CFO and Treasurer | Option exercise · Restricted Stock Units | −2,367 | 0 | ||
| 2024-06-30 | Alton Gregg H Director | Grant or award | +1,202 | $13.93 | $17K | 15,092 |
| 2024-06-30 | MCGLYNN MARGARET G Director | Grant or award | +713 | $13.93 | $10K | 13,212 |
| 2024-06-21 | YOUNG JAMES F Director | Sale | −7,500 | $14.09 | $106K | 61,760 |
| 2024-06-18 | YOUNG JAMES F Director | Sale | −6,393 | $13.62 | $87K | 70,367 |
| 2024-06-18 | YOUNG JAMES F Director | Sale | −1,107 | $14.28 | $16K | 69,260 |
| 2024-06-17 | Dubovsky Filip President, R&D | Option exercise | +1,404 | $6.97 | $10K | 68,017 |
| 2024-06-17 | Dubovsky Filip President, R&D | Option exercise | +12,500 | $6.09 | $76K | 80,517 |
| 2024-06-17 | Dubovsky Filip President, R&D | Sale | −12,500 | $14.46 | $181K | 68,017 |
| 2024-06-17 | Dubovsky Filip President, R&D | Sale | −1,404 | $14.54 | $20K | 66,613 |
| 2024-06-17 | Dubovsky Filip President, R&D | Option exercise · Stock Option (Right to Buy) | −1,404 | $6.97 | $10K | 46,324 |
| 2024-06-17 | Dubovsky Filip President, R&D | Option exercise · Stock Option (Right to Buy) | −12,500 | $6.09 | $76K | 37,500 |
| 2024-06-12 | MCGLYNN MARGARET G Director | Option exercise | +6,670 | 10,470 | ||
| 2024-06-12 | MCGLYNN MARGARET G Director | Option exercise · Restricted Stock Units | −6,670 | 0 | ||
| 2024-06-12 | MCGLYNN MARGARET G Director | Grant or award · Stock Option (Right to Buy) | +15,630 | $15.86 | $248K | 15,630 |
| 2024-06-12 | MCGLYNN MARGARET G Director | Grant or award · Restricted Stock Units | +10,420 | 10,420 | ||
| 2024-06-12 | Alton Gregg H Director | Option exercise | +6,670 | 10,470 | ||
| 2024-06-12 | Alton Gregg H Director | Option exercise · Restricted Stock Units | −6,670 | 0 | ||
| 2024-06-12 | Alton Gregg H Director | Grant or award · Stock Option (Right to Buy) | +15,630 | $15.86 | $248K | 15,630 |
| 2024-06-12 | Alton Gregg H Director | Grant or award · Restricted Stock Units | +10,420 | 10,420 |
Page 10 of 14 · 279 trades